Published in Immunology on December 01, 1986
Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates. Infect Immun (1989) 1.69
Mast cells in infection and immunity. Infect Immun (1997) 1.23
Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections. Infect Immun (1987) 1.21
Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J Clin Invest (1994) 1.19
Comparison of four hemolysin-producing organisms (Escherichia coli, Serratia marcescens, Aeromonas hydrophila, and Listeria monocytogenes) for release of inflammatory mediators from various cells. J Clin Microbiol (1988) 1.19
Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect Immun (1989) 1.06
Pore formation by the Escherichia coli alpha-hemolysin: role for mediator release from human inflammatory cells. Infect Immun (1994) 0.93
Effects of adhesins from mannose-resistant Escherichia coli on mediator release from human lymphocytes, monocytes, and basophils and from polymorphonuclear granulocytes. Infect Immun (1990) 0.86
Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin). Immunology (1993) 0.83
Induction of histamine release from rat mast cells and human basophilic granulocytes by clinical Escherichia coli isolates and relation to hemolysin production and adhesin expression. J Clin Microbiol (1988) 0.82
Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun (1977) 10.84
Cloning and functional characterization of the plasmid-encoded hemolysin determinant of Escherichia coli. J Bacteriol (1982) 3.82
Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity. Microbiol Rev (1984) 3.66
Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect Immun (1985) 3.58
A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field. Scand J Clin Lab Invest Suppl (1968) 3.28
Cloning of the chromosomal determinants encoding hemolysin production and mannose-resistant hemagglutination in Escherichia coli. J Bacteriol (1982) 3.28
Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03
Spontaneous deletions and flanking regions of the chromosomally inherited hemolysin determinant of an Escherichia coli O6 strain. J Bacteriol (1983) 2.61
Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice. Infect Immun (1983) 2.60
Lipopolysaccharide, capsule, and fimbriae as virulence factors among O1, O7, O16, O18, or O75 and K1, K5, or K100 Escherichia coli. Infect Immun (1984) 2.42
Effects of subminimal inhibitory concentrations of antibiotics on adhesiveness of Escherichia coli in vitro. Rev Infect Dis (1980) 2.12
The role of alpha haemolysin in the virulence of Escherichia coli for mice. J Med Microbiol (1982) 1.98
Characterization of pili associated with Escherichia coli O18ac. Infect Immun (1980) 1.80
Escherichia coli 987P pilus: purification and partial characterization. J Bacteriol (1981) 1.78
Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay. FEBS Lett (1982) 1.66
Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells. Infect Immun (1985) 1.61
Leukotriene B4: a mediator of vascular permeability. Br J Pharmacol (1981) 1.57
Chemical and immunological analysis of the complex structure of Escherichia coli alpha-hemolysin. J Bacteriol (1985) 1.46
Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34
Generation of leukotrienes from human granulocytes by alveolysin from Bacillus alvei. Infect Immun (1984) 1.30
Effects of low concentrations of antibiotics on Escherichia coli adhesion. Antimicrob Agents Chemother (1982) 1.25
Interaction of Escherichia coli with different fimbriae and polymorphonuclear leukocytes. Infect Immun (1982) 1.23
Generation of leukotrienes and lipoxygenase factors from human polymorphonuclear granulocytes during bacterial phagocytosis and interaction with bacterial exotoxins. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.14
Binding of rat IgE with the subcellular components of normal rat mast cells. Immunochemistry (1976) 1.08
Metabolism of leukotrienes by L-gamma-glutamyl-transpeptidase and dipeptidase from human polymorphonuclear granulocytes. Immunology (1985) 1.07
Eosinophil-rich human polymorphonuclear leukocyte preparations characteristically release leukotriene C4 on ionophore A23187 challenge. J Allergy Clin Immunol (1984) 1.06
The metabolism of leukotrienes in blood plasma studied by high-performance liquid chromatography. Biochim Biophys Acta (1985) 1.06
Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes. Infect Immun (1984) 1.01
Generation of slow-reacting substance (leukotrienes) by endotoxin and lipid A from human polymorphonuclear granulocytes. Immunology (1984) 1.00
Localization of 5-lipoxygenase within human polymorphonuclear leukocytes. Biochem Pharmacol (1985) 0.87
[A new method for synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide using 1-hydroxybenzotriazoles as additives]. Chem Ber (1970) 3.77
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol (1991) 3.60
Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol (1991) 2.72
Effects of subminimal inhibitory concentrations of antibiotics on adhesiveness of Escherichia coli in vitro. Rev Infect Dis (1980) 2.12
Escherichia coli adhesion to Saccharomyces cerevisiae and mammalian cells: role of piliation and surface hydrophobicity. Infect Immun (1981) 2.09
Swainsonine: an inhibitor of glycoprotein processing. Proc Natl Acad Sci U S A (1981) 2.01
Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis (1995) 1.97
Complement-dependent B-cell activation by cobra venom factor and other mitogens? J Exp Med (1974) 1.97
Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology (1994) 1.81
Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect Immun (1986) 1.70
Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation. Eur J Immunol (1973) 1.68
Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay. FEBS Lett (1982) 1.66
Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. J Clin Microbiol (2009) 1.62
Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells. Infect Immun (1985) 1.61
Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol (1991) 1.50
Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom. Immunology (1972) 1.47
Genetic classification and distinguishing of Staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences. J Clin Microbiol (2008) 1.47
Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549) Clin Exp Allergy (1999) 1.45
DNP-antigens activate the alternate pathway of the complement system. J Immunol (1974) 1.44
Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8. Infect Immun (1994) 1.44
[Heavy metal pollution of soil and garden products of Stolberg home gardens and lead and cadmium pollution of small farms in Stolberg]. Gesundheitswesen (1993) 1.39
Transforming growth factor beta 2 inhibits interleukin 1 beta- and tumour necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun (1991) 1.39
Effect of swainsonine on the processing of the asparagine-linked carbohydrate chains of alpha 1-antitrypsin in rat hepatocytes. Evidence for the formation of hybrid oligosaccharides. J Biol Chem (1983) 1.35
Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34
Intercellular adhesive specificity. Biochim Biophys Acta (1976) 1.33
Comparative study using various methods for identification of Staphylococcus species in clinical specimens. J Clin Microbiol (2006) 1.33
Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun (1994) 1.32
Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits. J Clin Invest (1981) 1.31
Generation of leukotrienes from human granulocytes by alveolysin from Bacillus alvei. Infect Immun (1984) 1.30
Arachidonic acid metabolites from polymorphonuclear leukocytes of healthy donors, severely burned patients and children with cystic fibrosis--routine monitoring by high-performance liquid chromatography. J Chromatogr (1988) 1.30
Swainsonine prevents the processing of the oligosaccharide chains of influenza virus hemagglutinin. J Biol Chem (1982) 1.28
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27
Effects of low concentrations of antibiotics on Escherichia coli adhesion. Antimicrob Agents Chemother (1982) 1.25
Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke. J Clin Invest (1987) 1.24
Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol (1976) 1.22
Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections. Infect Immun (1987) 1.21
Interleukin 1 beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem (1992) 1.20
Comparison of four hemolysin-producing organisms (Escherichia coli, Serratia marcescens, Aeromonas hydrophila, and Listeria monocytogenes) for release of inflammatory mediators from various cells. J Clin Microbiol (1988) 1.19
The neutrophil and leukotrienes--role in health and disease. Eicosanoids (1990) 1.17
Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J Clin Microbiol (2006) 1.17
Rapid ribosequencing--an effective diagnostic tool for detecting microbial infection. Infection (2001) 1.16
Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin Exp Rheumatol (1994) 1.16
Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation. Immunology (1979) 1.16
Subtyping of ST22-MRSA-IV (Barnim epidemic MRSA strain) at a university clinic in Germany from 2002 to 2005. J Med Microbiol (2007) 1.15
Heterogeneity of methicillin-susceptible Staphylococcus aureus strains at a German University Hospital implicates the circulating-strain pool as a potential source of emerging methicillin-resistant S. aureus clones. J Clin Microbiol (2006) 1.14
Generation of leukotrienes and lipoxygenase factors from human polymorphonuclear granulocytes during bacterial phagocytosis and interaction with bacterial exotoxins. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.14
Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells. Biochem Biophys Res Commun (1989) 1.13
Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology (1973) 1.13
Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg (1998) 1.12
Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr (2003) 1.10
Factor D in the alternate pathway of complement activation: purification, physicochemical characterization and functional role. Immunochemistry (1974) 1.09
Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes. Immunology (1988) 1.09
Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma (1997) 1.09
Genes controlling circadian rhythm are widely distributed in cyanobacteria. FEMS Microbiol Lett (2000) 1.08
Binding of rat IgE with the subcellular components of normal rat mast cells. Immunochemistry (1976) 1.08
Metabolism of leukotrienes by L-gamma-glutamyl-transpeptidase and dipeptidase from human polymorphonuclear granulocytes. Immunology (1985) 1.07
Role of Pseudomonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes, and monocytes. Infect Immun (1996) 1.06
The metabolism of leukotrienes in blood plasma studied by high-performance liquid chromatography. Biochim Biophys Acta (1985) 1.06
Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect Immun (1989) 1.06
[A new method for the synthesis of peptides: activation of the carboxy group with dicyclohexylcarbodiimide and 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazine]. Chem Ber (1970) 1.06
Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium. J Clin Microbiol (2008) 1.06
Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes. Immunology (1994) 1.06
Interleukin 6--a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma (1991) 1.05
Signal transduction in human platelets and inflammatory mediator release induced by genetically cloned hemolysin-positive and -negative Escherichia coli strains. Infect Immun (1990) 1.05
[Racemization in peptide syntheses]. Chem Ber (1970) 1.04
An assay for measuring specific adhesion of an Escherichia coli strain to tissue culture cells. Eur J Clin Microbiol (1982) 1.04
Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors. Immunology (1989) 1.03
Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid. Eur J Immunol (1978) 1.02
Immunologic properties of mast cells from rats infected with Nippostrongylus brasiliensis. J Immunol (1975) 1.02
Hydrogen peroxide as a potent bacteriostatic antibiotic: implications for host defense. Free Radic Biol Med (1995) 1.02
Effect of sodium fluoride on the generation of lipoxygenase products from human polymorphonuclear granulocytes, mononuclear cells and platelets--indication for the involvement of G proteins. Immunology (1989) 1.01
Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis (1998) 1.00
Generation of slow-reacting substance (leukotrienes) by endotoxin and lipid A from human polymorphonuclear granulocytes. Immunology (1984) 1.00
Comparison of the performance of the rapid antigen detection actim Influenza A&B test and RT-PCR in different respiratory specimens. J Med Microbiol (2009) 1.00
Properties of pili from Escherichia coli SS142 that mediate mannose-resistant adhesion to mammalian cells. J Bacteriol (1983) 0.98
The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma. Anticancer Res (1999) 0.98
Specific binding of mouse IgE with rat mast cells. J Immunol (1974) 0.98
Induction and comparison of the eosinophil chemotactic factor with endogenous hydroxyeicosatetraenoic acids: its inhibition by arachidonic acid analogs. Adv Prostaglandin Thromboxane Leukot Res (1982) 0.97
Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Immunology (1995) 0.97
Uptake, intracellular activity, and influence of rifampin on normal function of polymorphonuclear leukocytes. Antimicrob Agents Chemother (1985) 0.96
Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid. Immunology (1988) 0.96
Studies on the mechanisms of granulocyte dysfunctions in severely burned patients--evidence for altered leukotriene generation. J Trauma (1989) 0.95
Antibiotic action on phagocytosed bacteria measured by a new method for determining viable bacteria. Antimicrob Agents Chemother (1984) 0.95
Effects of Listeria monocytogenes and Yersinia enterocolitica on cytokine gene expression and release from human polymorphonuclear granulocytes and epithelial (HEp-2) cells. Infect Immun (1993) 0.95
Binding characteristics of aggregated IgGa to rat basophilic leukaemia (RBL) cells and rat mast cells. Immunology (1980) 0.94
Western blot analysis of water-soluble wheat flour (Triticum vulgaris) allergens. Int Arch Allergy Appl Immunol (1990) 0.94
Molecular effects of povidone-iodine on relevant microorganisms: an electron-microscopic and biochemical study. Dermatology (1997) 0.93
Characterization of leukotriene B4-omega-hydroxylase activity within human polymorphonuclear granulocytes. Scand J Immunol (1987) 0.93
Atriopeptin III induces endothelium-independent relaxation and increases cGMP levels in rabbit aorta. Klin Wochenschr (1986) 0.93
Pore formation by the Escherichia coli alpha-hemolysin: role for mediator release from human inflammatory cells. Infect Immun (1994) 0.93
Composition of staphylococcal bi-component toxins determines pathophysiological reactions. J Med Microbiol (1997) 0.93
Cytokine-induced (interleukins-3, -6 and -8 and tumour necrosis factor-beta) activation and deactivation of human neutrophils. Immunology (1992) 0.91
Assay of intercellular adhesiveness using cell-coated Sephadex beads as collecting particles. J Cell Sci (1976) 0.91
IL-8 release from human neutrophils by the respiratory syncytial virus is independent of viral replication. J Leukoc Biol (1996) 0.91
Subcellular localization of enzymes involved in leukotriene formation within human polymorphonuclear granulocytes. Immunology (1984) 0.91